Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT03227263

Completed

BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT). (BABH)

Telangiectasia, Hereditary Hemorrhagic | Rendu Osler Disease
NCT06022068

Completed

Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography (ERAP)

Alzheimer Disease
NCT05788289

Terminated

A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Mantle Cell Lymphoma | MCL
NCT06134622

Completed

Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT) (ASSET-IT)

Acute Ischemic Stroke
NCT06232902

Completed

A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers

Tumor
NCT04036448

Completed

A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea (RevlimidPMS)

Lymphoma, Follicular | Myelodysplastic Syndromes | Lymphoma, Mantle-Cell
NCT05704725

Completed

A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)

Chorioretinal Vascular Disease
NCT03676192

Completed

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Adenocarcinoma of Lung
NCT03923959

Completed

Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population (TAHFT)

Hip Fractures
NCT06330220

Completed

Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity

Age-Related Macular Degeneration
NCT04450329

Completed

A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Neovascular Age-related Macular Degeneration
NCT01166594

Completed

Use of Bevacizumab in Trabeculectomy Surgery

Fibrosis | Glaucoma | Optic Neuropathy
NCT01243476

Completed

Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome (SINTRA-REV)

Myelodysplastic Syndrome
NCT05189509

Completed

EXtending the tIme Window of Thrombolysis by ButyphThalide up to 6 Hours After Onset (EXIT-BT)

Stroke, Ischemic
NCT02257580

Completed

The Effect of Intravenous EACA on Blood Loss and Transfusion Requirements After Bilateral VRO

E-Aminocaproic Acid | Bilateral Varus Rotational Osteotomy
NCT01744912

Terminated

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell Lymphomas
NCT03672006

Completed

t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection (TOPCAT)

Central Venous Catheter Thrombosis | Central Venous Catheter Associated Bloodstream Infection
NCT02399592

Completed

Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer (Toco-Ovar)

Ovarian Cancer
NCT04527068

Unknown

QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer (BEVTOR)

MSS | pMMR | Refractory Metastatic Colorectal Cancer
NCT00049322

Completed

Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery

Liver Cancer
NCT01349660

Completed

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Glioblastoma Multiforme
NCT02206087

Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

Healthy
NCT04344782

Unknown

Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort (CORIMMUNO-BEVA)

COVID19 Pneumonia
NCT01967810

Completed

ANG1005 in Patients With Recurrent High-Grade Glioma

Glioma | Glioblastoma | Brain Tumor, Recurrent
NCT01972490

Completed

Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Colorectal Neoplasms
NCT01402531

Completed

Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia (HHT)
NCT01940523

Completed

Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical

Osteoarthritis
NCT02776683

Completed

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer (INVICTAN®-3)

Colorectal Neoplasms
NCT00622336

Completed

A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma

Multiple Myeloma
NCT01608087

Completed

Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects

Healthy
NCT04055194

Unknown

Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa

Placenta Previa
NCT01564914

Completed

A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma (105GM201)

Glioblastoma | Glioblastoma Multiforme
NCT03677466

Completed

Intramyocardial Haemorrhage in Patients With Primary STEMI (HaemInCor)

Myocardial Infarction | Myocardial Injury | STEMI | Myocardial Necrosis
NCT03885895

Unknown

Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser.

Therapeutic Efficacy
NCT00874978

Completed

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

Myelodysplastic Syndromes
NCT03267199

Unknown

The Relationship Between MPV,PDW,PFT and ST Segment Resolution in STEMI Patients Treated With Thrombolytic or Primary PCI

STEMI - ST Elevation Myocardial Infarction
NCT02375971

Completed

RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity (RAINBOW)

Retinopathy of Prematurity
NCT02155634

Withdrawn

Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma

Neoplasms | Hematologic Diseases | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Therapeutic Uses | Plasma Cells
NCT02393300

Completed

Comparison of Topical Versus Intravenous Tranexamic Acid in TKA

Total Blood Loss
NCT01245725

Withdrawn

Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention (ATLAST-PCI)

Myocardial Infarction | Percutaneous Coronary Intervention | Unstable Angina | Acute Coronary Syndromes
NCT03313401

Completed

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

Age Related Macular Degeneration
NCT01884597

Completed

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2) (PEARL2)

Polypoidal Choroidal Vasculopathy | PCV
NCT00976222

Completed

Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments

Pigment Epithelial Detachment
NCT01308528

Completed

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery

Venous Thromboembolism
NCT00473590

Completed

A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER) (AMBER)

Multiple Myeloma
NCT01077401

Completed

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study (READ 3)

Diabetic Macular Edema
NCT02050828

Completed

The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema (TIME-2)

Diabetic Macular Edema (DME)
NCT01443676

Completed

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)

Glioblastoma
NCT01251978

Completed

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)

Choroidal Melanoma
NCT00061178

Withdrawn

Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma

Renal Cell Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations